Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rritual Superfoods To Launch In CVS Stores Across US

Rritual Superfoods Inc (OTC:RRSFF) has announced its functional superfoods brand will launch in CVS Health Corp (NYSE:CVS) stores across the U.S. CVS will…
byShivani Kumaresan
June 29, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Rritual Superfoods Inc (OTC:RRSFF) has announced its functional superfoods brand will launch in CVS Health Corp (NYSE:CVS) stores across the U.S.
  • CVS will carry Rritual’s full individual product line including, Chaga IMMUNE, Lion’s Mane FOCUS, and Reishi RELAX.
  • Rritual will work with CVS to develop an in-store education program for CVS-trained professionals to serve CVS consumers best.
  • “In terms of the Rritual brand, placement with CVS further establishes confidence in our products and escalating demand for this category with consumers,” said David Kerbel, Chief Executive Officer, Rritual.
  • Price action: RRSFF shares closed lower by 1.75% at $0.59 on the last check Tuesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Datopotamab Deruxtecan Showed Encouraging and Durable Efficacy in Patients With Heavily Pretreated HR-positive, HER2-Low or Negative Metastatic Breast Cancer

By Charles Gross
Today, 10:06 PM
First results for AstraZeneca and Daiichi Sankyo's TROP2-directed ADC in this setting reported from TROPION-PanTumor01 Phase I trial. Pivotal TROPION-Breast01 Phase III trial is ongoing, evaluating datopotamab deruxtecan in these patients in earlier lines of treatment.

AZN